BC

Broadfin Capital Portfolio holdings

AUM $403M
1-Year Est. Return 74.97%
This Quarter Est. Return
1 Year Est. Return
+74.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.03B
AUM Growth
+$274M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
97
New
Increased
Reduced
Closed

Top Buys

1
+$34.1M
2
+$31.1M
3
+$21M
4
AVDL
Avadel Pharmaceuticals
AVDL
+$20.1M
5
EBS icon
Emergent Biosolutions
EBS
+$18.5M

Top Sells

1
+$29.1M
2
+$23.4M
3
+$22.5M
4
NVDQ
Novadaq Technologies Inc.
NVDQ
+$16.6M
5
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$14.9M

Sector Composition

1 Healthcare 79.95%
2 Technology 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$2.62M 0.25%
+160,597
77
$2.57M 0.25%
95,791
78
$2.42M 0.23%
215,962
79
$2.4M 0.23%
10,000
80
$2.15M 0.21%
+50,000
81
$1.81M 0.18%
+50,000
82
$1.58M 0.15%
+200,000
83
$1.54M 0.15%
+55,000
84
$1.14M 0.11%
6,650
+2,160
85
$641K 0.06%
64,035
-413,232
86
– –
-30,831
87
– –
-380
88
– –
-25,000
89
– –
-150,000
90
– –
-391,232
91
– –
-100,000
92
– –
-543,466
93
– –
-100
94
– –
-15,000
95
– –
-400,000
96
– –
-188,706
97
– –
-3,356,391
1 2 3
4